Tyler R. McCaw

This study shows that entinostat enhances CD8+ T cell responses in tumors but only when administered during a specific window after T cell activation, and this effect can be restored by prior oncolytic virus treatment.

This study shows that inhibiting AXL in pancreatic cancer cells enhances immune checkpoint therapy by blocking non-professional efferocytosis and increasing CD8 T cell infiltration.